HIGHLIGHTS
- who: January and colleagues from the Indian Institute of Technology Indore, Jamia Hamdard, India have published the Article: Targeting Kaposi associated herpesvirus encoded protease (ORF17) by a lysophosphatidic acid molecule for treating KSHV associated diseases, in the Journal: (JOURNAL)
- what: The authors investigated effect of physiological allowed condition of hypoxia and chemical inducers of KSHV reactivation on the expression of KSHV-encoded protease (ORF17). The study propose use of 1oleoyl-2-hydroxy-sn-glycero-3-phospho-(1u2032-myo-inositol) as an alternate approach in management of KSHV associated pathogenesis.
SUMMARY
Treatment . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.